Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.884
-0.056 (-1.93%)
Nov 21, 2024, 12:39 PM EST - Market open
Lantern Pharma Employees
Lantern Pharma had 21 employees as of December 31, 2023. The number of employees decreased by 2 or -8.70% compared to the previous year.
Employees
21
Change (1Y)
-2
Growth (1Y)
-8.70%
Revenue / Employee
n/a
Profits / Employee
-$909,140
Market Cap
31.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
HOOKIPA Pharma | 179 |
Passage Bio | 58 |
Curis | 49 |
Citius Pharmaceuticals | 22 |
BioVie | 14 |
Eterna Therapeutics | 8 |
LTRN News
- 2 days ago - Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients - Business Wire
- 12 days ago - Lantern Pharma Inc. (LTRN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates - Business Wire
- 16 days ago - Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board - Business Wire
- 21 days ago - Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET - Business Wire
- 4 weeks ago - Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024 - Business Wire
- 4 weeks ago - Lantern Pharma to Host & Participate in Two Public Webinars During October - Business Wire
- 5 weeks ago - Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA - Business Wire